Neri Loris, Di Liberato Lorenzo, Alfano Gaetano, Allegrucci Valeria, Appio Nicoletta, Bussi Carla, Cannarile Daniela Cecilia, De Palma Ilaria, Di Stante Silvio, Pacifico Rosa, Panuccio Vincenzo, Porreca Silvia, Terlizzi Vincenzo, D'Alonzo Silvia, Viglino Giusto
Nephrology and Dialysis Unit, Ospedale "Michele e Pietro Ferrero", Via Tanaro, 7-9, Verduno, 12060 Cuneo, Italy.
Nephrology and Dialysis Unit, Department of Medicine, G. d'Annunzio University, Chieti-Pescara, SS. Annunziata Hospital, 66100 Chieti, Italy.
J Pers Med. 2024 Jul 30;14(8):807. doi: 10.3390/jpm14080807.
The management of end-stage kidney disease (ESKD) has been constantly evolving over the last decade with the development of targeted approaches. In this field, telemedicine and remote monitoring are based on the availability of new cyclers that allow for bidirectional communication (between patient and physician) and for the application of the Sharesource cloud-based platform. These technologies allow patients with ESKD to undergo automated peritoneal dialysis (APD) at home. However, these approaches are not well standardized and largely applied yet. Therefore, this study aimed to elaborate a protocol for the utilization of the Sharesource platform to facilitate the practical management of patients treated with APD. A series of expert meetings were held between September 2022 and January 2023 in Italy. The participants (ten nephrologists and five nurses) from nine Italian public dialysis centers shared their opinions, examined the current scientific literature in the field, and reviewed the key characteristics of the Sharesource system to achieve a common position on this topic. A detailed and practical document containing experts' opinions and suggestions on the use of the Sharesource platform for the management of patients treated with APD was produced. This expert opinion might represent a new useful instrument in clinical practice for managing patients undergoing home-based peritoneal dialysis (PD) through the Sharesource platform, which is valid not only for Italy. These recommendations pave the way to novel patient-centered and personalized therapeutic approaches for ESKD and highlight the advantages of telemedicine and remote monitoring in the management of patients with ESKD undergoing PD and its positive impact on their quality of life.
在过去十年中,随着靶向治疗方法的发展,终末期肾病(ESKD)的管理一直在不断演变。在这一领域,远程医疗和远程监测基于新型循环仪的应用,这些循环仪支持双向通信(患者与医生之间)以及基于Sharesource云平台的应用。这些技术使ESKD患者能够在家中进行自动化腹膜透析(APD)。然而,这些方法尚未得到很好的标准化,应用也不广泛。因此,本研究旨在制定一项利用Sharesource平台的方案,以促进接受APD治疗患者的实际管理。2022年9月至2023年1月在意大利举行了一系列专家会议。来自九个意大利公共透析中心的参与者(十位肾病学家和五位护士)分享了他们的意见,研究了该领域当前的科学文献,并审查了Sharesource系统的关键特性,以就该主题达成共识。生成了一份详细实用的文件,其中包含专家对使用Sharesource平台管理接受APD治疗患者的意见和建议。这一专家意见可能成为临床实践中通过Sharesource平台管理接受家庭腹膜透析(PD)患者的一种新的有用工具,不仅对意大利有效。这些建议为ESKD以患者为中心的新型个性化治疗方法铺平了道路,并突出了远程医疗和远程监测在管理接受PD的ESKD患者中的优势及其对患者生活质量的积极影响。